theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Primary Care

Erosive osteoarthritis   

Questions discussed in this category


What is your approach to refractory erosive osteoarthritis?
Significant impact on ADLs and no response to doxycycline, hydroxychloroquine, sulfasalazine or methotrexate.
2 Answers available

Are there any new treatments for erosive osteoarthritis of the hands?
1 Answer available
130028471


Papers discussed in this category


Osteoarthritis Cartilage, 2018 Mar 02
A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis - the HUMOR trial.

Ann Rheum Dis, 2018 Oct 03
Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial.

Ann Rheum Dis, 2018 Dec 14
Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis.

Lancet, 2019 Nov 11
Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial.

Related Topics in Primary Care

  • Lung Cancer
  • Workload
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers

Copyright © 2025 theMednet
All Rights Reserved.